MedPath

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group

Phase 3
Completed
Conditions
Non Alcoholic Fatty Liver Disease
Interventions
Registration Number
NCT01754714
Lead Sponsor
Abbott
Brief Summary

Investigation the Effects of Different Doses of SAMe in Subjects with Nonalcoholic Fatty Liver Disease and non-treated matched healthy volunteers as control group

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1500 mg SAMeSAMe 1500 mg-
2000 mg SAMeSAMe 2000 mg-
1000 mg SAMe (S-adenosyl-L-methionine)SAMe 1000 mg-
Primary Outcome Measures
NameTimeMethod
Methionine Elimination Half-life Measured in Blood.0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours*at Week 7*

After the methionine load, blood samples will be obtained at 0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours. Plasma will be analyzed for methionine.

Secondary Outcome Measures
NameTimeMethod
Metabolic Panel (Metabolic Laboratory Parameters)change from baseline at 6 weeks

Adiponectin

The Metabolic Clearance Rate Measured in the Blood.0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours*at Week 7*

After the methionine load, blood samples will be obtained at 0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours. Plasma will be analyzed for methionine.

13 Carbon (Natural, Stable Isotope of Carbon) Methionine Breath Test0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours*at Week 7*

Time to peak

Methionine Volume of Distribution at Week 7 (L)0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours*at Week 7*

After the methionine load, blood samples will be obtained at 0.5, 1, 1.5, 3, 4, 5, 6, 7.5 and 9 hours. Plasma will be analyzed for methionine.

Area Under Curve (AUC) of Average Methionine Concentration Versus Time Curve0.5, 1, 1.5, 3, 4, 5, 6, 7.5 and 9 hours *at Week 7*

After the methionine load, blood samples will be obtained at 0.5, 1, 1.5, 3, 4, 5, 6, 7.5 and 9 hours. Plasma will be analyzed for methionine.

Fasting Methionine Concentration of Average Methionine Concentration Versus Time Curve.0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours*at Week 7*

After the methionine load, blood samples will be obtained at 0.5, 1, 1.5, 3, 4.5, 6, 7.5 and 9 hours. Plasma will be analyzed for methionine.

Hepatic Panel (Liver Laboratory Parameters)change from baseline at 6 weeks

ALT/AST ratio

Immunological/Anti-oxidant Panel (Immunological and Anti-oxidant Laboratory Parameters)change from baseline at 6 weeks

oxidative stress marker (isoprostane level)

Fibrosis and Apoptosis Markers (Fibrosis and Apoptosis Laboratory Markers)change from baseline at 6 weeks

Hyaluronic acid

Trial Locations

Locations (32)

Site Reference ID 93954

🇩🇪

Frankfurt, Germany

Site Reference ID 93916

🇫🇷

Nice, France

Site Reference ID 93895

🇫🇷

Angers, France

Site Reference ID 93893

🇫🇷

Paris, France

Site Reference ID 93935

🇩🇪

Freiburg, Germany

Site Reference ID 93894

🇫🇷

Bobigny, France

Site Reference ID 93913

🇫🇷

Montpellier, France

Site Reference ID 93915

🇫🇷

Paris, France

Site Reference ID 93914

🇫🇷

Amiens, France

Site Reference ID 94014

🇩🇪

Ulm, Germany

Site Reference ID 93974

🇵🇱

Warsaw, Poland

Site Reference ID 93953

🇩🇪

Bonn, Germany

Site Reference ID 93896

🇫🇷

Pessac, France

Site Reference ID 93955

🇩🇪

Halle, Germany

Site Reference ID 94015

🇩🇪

Leipzig, Germany

Site Reference ID 93918

🇩🇪

Mainz, Germany

Site Reference ID 93917

🇩🇪

Hannover, Germany

Site Reference ID 93933

🇩🇪

Homburg, Germany

Site Reference ID 93973

🇵🇱

Krakow, Poland

Site reference ID/Investigator # 109455

🇵🇱

Bydgoszcz, Poland

Site Reference ID 93958

🇵🇱

Chorzow, Poland

Site Reference ID 93957

🇵🇱

Myslowice, Poland

Site reference ID ORG-000907

🇷🇺

Novosibirsk, Russian Federation

Site reference ID ORG-000905

🇷🇺

Krasnoyarsk, Russian Federation

Site reference ID ORG-000906

🇷🇺

Moscow, Russian Federation

Site reference ID ORG-000900

🇷🇺

Nizhniy Novgorod, Russian Federation

Site reference ID ORG-000903

🇷🇺

Omsk, Russian Federation

Site reference ID ORG-000920

🇷🇺

Rostov-on-Don, Russian Federation

Site reference ID ORG-000904

🇷🇺

Samara, Russian Federation

Site reference ID ORG-000901

🇷🇺

Stavropol, Russian Federation

Site Reference ID 93975

🇵🇱

Wroclaw, Poland

Site Reference ID 93956

🇵🇱

Lodz, Poland

© Copyright 2025. All Rights Reserved by MedPath